MIM
GMAB icon

Macroview Investment Management’s Genmab GMAB Stock Holding History

Macroview Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45
Closed -$1.59K – 718
2023
Q3 		$1.59K Buy
+45
New +$1.72K ﹤0.01% 593

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Macroview Investment Management's GMAB Position: Q4 2023 in Review

Macroview Investment Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 45 shares — an estimated $1.59K sold.

Macroview Investment Management first reported a position in GMAB in Q3 2023 and held it in 1 quarter. The position peaked at $1.59K in Q3 2023. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Macroview Investment Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Macroview Investment Management sold 45 Genmab shares in Q4 2023, an estimated $1.59K.
  • Macroview Investment Management first reported a position in Genmab in Q3 2023 and held it in 1 quarter.
  • Macroview Investment Management's Genmab position peaked at $1.59K in Q3 2023.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.